Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Gregory Carbonetti currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This active matter is under the review of NOLAN, JASON MICHAEL, who is designated as the busiest examiner for the portfolio. The prosecution footprint is minimal, featuring 1 distinct examiner and 1 distinct art unit. As a result, NOLAN, JASON MICHAEL is handling the 1 busiest examiner pending action currently active.
The concentration of the 1 pending office action within a single art unit indicates a focused intellectual property strategy. Because there is only 1 distinct examiner involved, the applicant can focus their efforts on the specific examination style of NOLAN, JASON MICHAEL. This arrangement in the 1 distinct art unit avoids the complexities of managing disparate procedural requirements across different USPTO divisions. The 1 busiest examiner pending case represents the entirety of the current office action workload for this 1 distinct art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NOLAN, JASON MICHAEL | 1 | 66.6% | -27.2% |
| Art Unit | Apps |
|---|---|
| 1623 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17779214 | COMBINATION THERAPY USING FABP5 INHIBITORS WITH TAXANES FOR TREATMENT OF CANCER | NOLAN, JASON MICHAEL | 1623 | §103Other | Non-Final OA | — | Pending | May 24, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGregory Carbonetti has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jason Michael Nolan has the most, with 1 of Gregory Carbonetti's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
